VivoSeq
Other

Hair Loss

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Hair Loss is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

16

clinical trials

Completed13 · 81%
Not yet recruiting1 · 6%
Active, not recruiting1 · 6%
Unknown status1 · 6%

Clinical Trials

Trial Activity

16 trials

A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors
Active, not recruiting·MMemorial Sloan Kettering Cancer Center·Phase 2·NCT05778825·10 enrolled
Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss
Not yet recruiting·AAche Laboratorios Farmaceuticos S.A.·Phase 4·NCT06355856·196 enrolled
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012)
Completed·—·Phase 2·NCT01451047·31 enrolled
Efficacy Study of Minoxidil Lotion Versus Combined Minoxidil and Finasteride Lotion to Treat Male Pattern Hair Loss
Completed·MMae Fah Luang University Hospital·Phase 3·NCT01391156·40 enrolled
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)
Completed·—·Phase 2·NCT01451151·33 enrolled
A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss
Completed·—·Phase 2·NCT01451099·21 enrolled
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)
Completed·—·Phase 2·NCT01451125·43 enrolled
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)
Completed·—·Phase 2·NCT01451190·88 enrolled
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)
Completed·—·Phase 2·NCT01451177·43 enrolled
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)
Completed·—·Phase 2·NCT01451138·40 enrolled
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss
Completed·—·Phase 2·NCT01451021·21 enrolled
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)
Completed·—·Phase 2·NCT01669746·34 enrolled
Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss
Completed·NNeosil, Inc.·Phase 2·NCT00418730·180 enrolled
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)
Completed·—·Phase 2·NCT01451112·30 enrolled
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013)
Completed·—·Phase 2·NCT01451073·33 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)